ALAD Gene Acute Hepatic Porphyria Genetic Test
At DNA Labs UAE, we offer the ALAD Gene Acute Hepatic Porphyria Genetic Test to help diagnose and manage acute hepatic porphyria. This test analyzes the ALAD gene, which is responsible for encoding the enzyme delta-aminolevulinic acid dehydratase (ALAD).
Test Components
- ALAD Gene Acute Hepatic Porphyria Genetic Test
Price
4400.0 AED
Sample Condition
Blood
Report Delivery
3 to 4 Weeks
Method
NGS Technology
Test Type
Metabolic Disorders
Doctor
General Physician
Test Department
Genetics
Pre Test Information
Before undergoing the ALAD Gene Acute Hepatic Porphyria Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by Acute Hepatic Porphyria.
Test Details
Acute hepatic porphyria is a rare genetic disorder characterized by the abnormal accumulation of porphyrins in the liver. It can cause various symptoms, including abdominal pain, nausea, vomiting, constipation, muscle weakness, and neurological symptoms such as seizures and psychosis.
NGS (Next-Generation Sequencing) genetic testing is a cutting-edge technology used to analyze multiple genes simultaneously. In the case of acute hepatic porphyria, NGS genetic testing can identify mutations in the ALAD gene that may be responsible for the disorder.
By identifying specific mutations in the ALAD gene, NGS genetic testing can aid in the accurate diagnosis of acute hepatic porphyria. It also provides valuable information for the management and treatment of the condition. The test can be used for carrier testing and prenatal testing in families with a known history of the disorder.
Overall, the ALAD Gene Acute Hepatic Porphyria Genetic Test using NGS technology is crucial for accurate diagnosis, genetic counseling, and personalized treatment strategies for individuals affected by acute hepatic porphyria.
| Test Name | ALAD Gene Acute hepatic porphyria Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Metabolic Disorders |
| Doctor | General Physician |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for ALAD Gene Acute hepatic porphyria NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Acute hepatic porphyria |
| Test Details |
The ALAD gene is responsible for encoding the enzyme delta-aminolevulinic acid dehydratase (ALAD). Mutations in this gene can cause a rare genetic disorder called acute hepatic porphyria. Acute hepatic porphyria is a group of metabolic disorders characterized by the abnormal accumulation of porphyrins in the liver. This can lead to a variety of symptoms, including abdominal pain, nausea, vomiting, constipation, muscle weakness, and neurological symptoms such as seizures and psychosis. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of acute hepatic porphyria, NGS genetic testing can be used to identify mutations in the ALAD gene that may be responsible for the disorder. By identifying specific mutations in the ALAD gene, NGS genetic testing can help diagnose acute hepatic porphyria and provide valuable information for the management and treatment of the condition. It can also be used for carrier testing and prenatal testing in families with a known history of the disorder. Overall, NGS genetic testing for the ALAD gene in acute hepatic porphyria can aid in accurate diagnosis, genetic counseling, and personalized treatment strategies for affected individuals. |
